摘要:
Disclosed are peptides of Angiopoietin - 2. Also disclosed are peptides comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
摘要:
Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
摘要:
Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies , and methods of treatment using such peptides and peptibodies.
摘要:
Disclosed are peptides that bind to Angiopoietin - 2. Also disclosed are peptides comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
摘要:
Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
摘要:
Disclosed are peptides that bind to Angiopoietin - 2. Also disclosed are peptides comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
摘要:
Disclosed are peptides that bind to Angiopoietin - 2. Also disclosed are peptides comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
摘要:
Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
摘要:
Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.